Abacavir + Lamivudina Aurovitas

Abacavir + Lamivudina Aurovitas is a combination medication used in the treatment of HIV infection. This oral medication is manufactured by Generis Farmacêutica, S.A. and is commonly prescribed as part of antiretroviral therapy.

Abacavir + Lamivudina Aurovitas is primarily used in the management of HIV infection. This combination therapy helps to reduce the amount of HIV in the body, improving immune function and reducing the risk of HIV-related complications. It is often used as part of a broader treatment plan that includes other medications and lifestyle changes.

Common effects of Abacavir + Lamivudina Aurovitas may include nausea, fatigue, and headache. Some individuals may also experience changes in body fat distribution. It is important to discuss any persistent or severe side effects with a healthcare provider.

Abacavir + Lamivudina Aurovitas should be used with caution in individuals with a history of liver disease or kidney problems. Regular monitoring of liver function and kidney function may be recommended. Always follow the advice of a healthcare professional regarding the use of this medication.

Abacavir + Lamivudina Aurovitas may interact with other medications, including certain antiretrovirals and drugs that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.